Adjustments related to prior year sales Gross To Net Adjustments Reserve Provision Related To Prior Period Sales Gross To Net Adjustments Reserve Provision Related To Prior Period Sales Rebates, Customer Fees/Credits, Co-Pay Assistance, and Other Rebates, Customer Fees, Credits, Co Pay Assistance, And Other [Member] Rebates, Customer Fees, Credits, Co Pay Assistance, And Other Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Range [Domain] Statistical Measurement [Domain] Unrealized losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Tax benefit at U.S. federal statutory rate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Summary of Cash, Cash Equivalents and Investments Cash, Cash Equivalents and Investments [Table Text Block] Cover [Abstract] Cover [Abstract] Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Schedule of Future Minimum Payments for Operating Leases Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Income Tax Jurisdiction [Domain] Income Tax Jurisdiction [Domain] Trading Symbol Trading Symbol Customer B Customer B [Member] Customer B All Trading Arrangements All Trading Arrangements [Member] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Number of core values supporting Segment Reporting, Number Of Core Values Supporting Operating Decisions Segment Reporting, Number Of Core Values Supporting Operating Decisions Non-NEOs Non-NEOs [Member] Income tax related interest and penalties Income Tax Examination, Penalties and Interest Expense Research and development tax credit carryforwards Tax Credit Carryforward, Amount Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Commitments and Contingencies Other Commitments [Line Items] Pay vs Performance Disclosure [Line Items] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Trade receivables, net Increase (Decrease) in Accounts Receivable Variable Rate Component One Variable Rate Component One [Member] Variable Rate Component One Sale of stock, minimum required percentage of ownership after transaction Class Of Warrant Or Right, Beneficial Ownership, Exercise Threshold Class Of Warrant Or Right, Beneficial Ownership, Exercise Threshold Basic and Diluted Loss Per Common Share Earnings Per Share, Policy [Policy Text Block] Organization, Business and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Inventory Inventory, Policy [Policy Text Block] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Proceeds resulting from exercise of stock options Proceeds from Stock Options Exercised Line of credit facility, interest rate Line of Credit Facility, Interest Rate at Period End Award Timing Disclosures [Line Items] Other Performance Measure, Amount Other Performance Measure, Amount Leases Lessee, Operating Leases [Text Block] Common stock, outstanding (shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Operating lease costs Operating Lease, Cost Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Shares available for future issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Lease liability Operating Lease, Liability, Noncurrent Shannon Kelley [Member] Shannon Kelley Stockholders' Equity (Deficit) Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Revenue from Contract with Customer [Abstract] Plan Name [Domain] Plan Name [Domain] Sale of stock, price per share (in dollars per share) Sale of Stock, Price Per Share Proceeds from issuance or sale of equity Proceeds from Issuance or Sale of Equity Entity Tax Identification Number Entity Tax Identification Number Gross to net accruals Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Gross To Net Accruals Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Gross To Net Accruals Leases [Abstract] Leases [Abstract] Loan Facility, Tranche 4 Loan Facility, Tranche Four [Member] Loan Facility, Tranche Four Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] R&D credit Deferred Tax Assets, Tax Credit Carryforwards, Research Money market funds Money Market Funds [Member] Selling, general and administrative Selling, General and Administrative Expenses [Member] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Cash received on stock transaction after deduction of issuance costs Sale of Stock, Consideration Received on Transaction Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Summary of performance-based restricted stock units Share-Based Payment Arrangement, Performance Shares, Outstanding Activity [Table Text Block] Secured Debt Secured Debt [Member] Property, plant & equipment Deferred Tax Assets, Property, Plant and Equipment Plan Name [Axis] Plan Name [Axis] 2024 Sales Agreement And Sales Agreement Amendment 2024 Sales Agreement And Sales Agreement Amendment [Member] 2024 Sales Agreement And Sales Agreement Amendment Equity Components [Axis] Equity Components [Axis] Award Timing Method Award Timing Method [Text Block] Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Fair value Debt Securities, Available-for-Sale Trade Receivables, Net Accounts Receivable [Policy Text Block] Stock price discount per common share (in dollars per share) Class Of Warrant Or Right, Stock Price Discount Per Common Share Class Of Warrant Or Right, Stock Price Discount Per Common Share Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Insider Trading Policies and Procedures [Line Items] Revision of Prior Period, Adjustment Revision of Prior Period, Adjustment [Member] Mardi Dier [Member] Mardi Dier Use of Estimates Use of Estimates, Policy [Policy Text Block] Total operating expenses Costs and Expenses Amortization and interest accretion related to operating leases Operating Lease, Right-Of-Use Asset, Periodic Reduction (Increase) Operating Lease, Right-Of-Use Asset, Periodic Reduction (Increase) Adjustment to Compensation, Amount Adjustment to Compensation Amount Outstanding at the end of the year Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Additional paid-in-capital Additional Paid in Capital, Common Stock Compensation Amount Outstanding Recovery Compensation Amount Supplemental disclosure of cash flow information: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Entity Small Business Entity Small Business Eligible to Earn PSUs Eligible to Earn Performance Share [Member] Eligible to Earn Performance Share Accrued Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Company Selected Measure Amount Company Selected Measure Amount Payment of debt issuance costs Payments of Debt Issuance Costs Tabular List, Table Tabular List [Table Text Block] Net deferred tax assets Deferred Tax Assets, Net Increase in valuation allowance Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Unrecognized stock-based compensation expense Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Stock based compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount Number of securities called by warrants (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Accrued liabilities Total accrued liabilities Accrued Liabilities, Current Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Credit Facility [Domain] Credit Facility [Domain] Corporate Debt Securities due within 1 to 2 years of date of purchase Corporate Debt Securities Due Within One To Two Years Of Date Of Purchase [Member] Corporate Debt Securities Due Within One To Two Years Of Date Of Purchase Cash, cash equivalents, and restricted cash at beginning of period Cash, cash equivalents, and restricted cash at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Unrecognized stock compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Current assets: Assets, Current [Abstract] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Authorized capital Share Repurchase Program, Authorized, Amount Inventory Inventory Disclosure [Text Block] Aggregate intrinsic value (in thousands) Share Based Compensation Arrangement by Share Based Payment Award, Options Outstanding Aggregate Intrinsic Value [Abstract] Share Based Compensation Arrangement by Share Based Payment Award, Options Outstanding Aggregate Intrinsic Value [Abstract] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Product and Service [Domain] Product and Service [Domain] Common stock options Share-Based Payment Arrangement, Option [Member] Vested (in dollars per share) PSUs attained (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value 2025 Lessee, Operating Lease, Liability, to be Paid, Year One Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Security, Excluded EPS Calculation [Table] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Patent expenses Patent Costs The amount of costs to secure and defend patents expenses in the statements of operations. Preferred stock, outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Preferred Stock, Shares Outstanding Number of votes per share that common stockholders are entitled to receive Common Stock Voting Rights Number Represents the number of votes per share that common stockholders are entitled to receive. Warrants Warrant [Member] Security Exchange Name Security Exchange Name Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Award Type [Axis] Award Type [Axis] Corporate Debt Securities Corporate Debt Securities [Member] Options exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Research and development - external expense Research and Development External Expense Research and Development External Expense Work in process Inventory, Work in Process, Net of Reserves Property and equipment, net Property, Plant and Equipment, Net ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Total liabilities Liabilities Exercisable at the end of the year (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Proceeds from issuance of common stock, gross Sale Of Stock, Consideration Received On Transaction, Gross Sale Of Stock, Consideration Received On Transaction, Gross Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Manufacturing and drug supply Accrued Manufacturing and Drug Supply Current Accrued manufacturing and drug supply Current. Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Expiration Date Trading Arrangement Expiration Date Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Lease liability Operating Lease, Liability, Current Total Shareholder Return Amount Total Shareholder Return Amount Common stock, issued (shares) Common Stock, Shares, Issued Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Additional Drawn Line of Credit Facility, Maximum Borrowing Capacity Concentration risk, percentage Concentration Risk, Percentage Public Offering, 2024 Public Offering, 2024 [Member] Public Offering, 2024 Net operating losses Deferred Tax Assets, Operating Loss Carryforwards Cost Cash, Cash Equivalents, and Short-term Investments, At Cost This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings, and cash and cash equivalents. Other adjustments Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Sale of warrants and common shares to related parties and exercise of common stock options, net of transaction costs (in shares) Options exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Capitalized R&D Deferred Tax Assets, Deferred Expense, Capitalized Research and Development Costs Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from research and development costs. Debt Instrument [Line Items] Debt Instrument [Line Items] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Research and development Research and Development Expense [Member] Weighted average exercise price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Common stock, authorized (in shares) Common Stock, Shares Authorized Loan Facility, Tranches 2 and 3 Loan Facility, Tranches Two and Three [Member] Loan Facility, Tranches Two and Three Cash Cash [Member] Unrealized gain on available-for-sale securities Unrealized gain on marketable securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Diluted weighted average number of common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Intangibles Deferred Tax Assets, Goodwill and Intangible Assets Other comprehensive income: Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Line of credit facility, increase In maximum borrowing capacity Line Of Credit Facility, Increase In Maximum Borrowing Capacity Line Of Credit Facility, Increase In Maximum Borrowing Capacity MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Minimum liquidity covenant Debt Instrument, Covenant, Liquidity, Minimum Debt Instrument, Covenant, Liquidity, Minimum Debt instrument, covenant, market capitalization minimum Debt Instrument, Covenant, Market Capitalization Minimum Debt Instrument, Covenant, Market Capitalization Minimum Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Total deferred tax assets before valuation allowance Deferred Tax Assets, Gross Liquidity and Uncertainties Liquidity and Uncertainties Liquidity And Uncertainties Disclosure Abstract Entity Voluntary Filers Entity Voluntary Filers Operating Leases Operating Lease, Liability [Abstract] Proceeds from issuance of debt Proceeds from Issuance of Debt 162M limitation Effective Income Tax Rate Reconciliation, 162M Limitation, Amount Effective income tax rate reconciliation, 162M limitation, amount. Related Party Related Party [Member] Interest expense Interest Expense, Nonoperating Concentration Risk Type [Domain] Concentration Risk Type [Domain] Accounting Standards Update and Change in Accounting Principle [Table] Accounting Standards Update and Change in Accounting Principle [Table] Selling, general and administrative Selling, general and administrative Selling, General and Administrative Expense Trade receivables, net Accounts Receivable, after Allowance for Credit Loss, Current Options granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Accrued interest payments, term Debt Instrument, Accrued Interest Payments, Term Debt Instrument, Accrued Interest Payments, Term Sale of Stock [Domain] Sale of Stock [Domain] Anti-dilutive securities Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Long-term debt Loans payable, net of discount Long-Term Debt Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Document Fiscal Period Focus Document Fiscal Period Focus All Executive Categories All Executive Categories [Member] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Outstanding at the end of the year Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Assets Assets [Abstract] Restricted cash Restricted Cash, Current Document Type Document Type Term charges on aggregate principal amount, percentage Line of Credit Facility, Commitment Fee Percentage Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Schedule of Segment Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Less amount representing interest Interest Expense, Debt, Excluding Amortization Document Annual Report Document Annual Report Nonrelated Party Nonrelated Party [Member] Exercisable at the end of the year Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Vested (in shares) PSUs attained (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Cost Debt Securities, Available-for-Sale, Amortized Cost Hoffmann-La Roche ("Roche") Hoffman La Roche [Member] Represents information pertaining to Hoffman-La Roche. Customer D Customer D [Member] Customer D Exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Exercisable, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Exercisable, Weighted Average Grant Date Fair Value Maximum Maximum [Member] Marketable securities: Debt Securities, Available-for-Sale [Abstract] Long term debt floor interest rate percentage Long Term Debt Floor Interest Rate Percentage Long term debt floor interest rate percentage. Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Intangible assets, net Finite-Lived Intangible Assets, Net Antidilutive Securities [Axis] Antidilutive Securities [Axis] Accounts payable Accounts Payable, Current Loan Facility, Tranche 3 Loan Facility, Tranche Three [Member] Loan Facility, Tranche Three Accounting Policies [Abstract] Accounting Policies [Abstract] Revenues: Revenues [Abstract] Less unamortized discount Debt Instrument, Unamortized Discount Current Fiscal Year End Date Current Fiscal Year End Date Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Statistical Measurement [Axis] Statistical Measurement [Axis] PEO Name PEO Name Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Equity Award [Domain] Award Type [Domain] Name Outstanding Recovery, Individual Name Stock compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Provision related to sales in the current year Gross To Net Adjustments Reserve Provision Related To Current Period Sales Gross To Net Adjustments Reserve Provision Related To Current Period Sales Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Revision of Prior Period [Axis] Revision of Prior Period [Axis] Non-PEO NEO Non-PEO NEO [Member] Additional paid-in Capital Additional Paid-in Capital [Member] Carole Huntsman [Member] Carole Huntsman Award Timing Predetermined Award Timing Predetermined [Flag] Performance-based restricted stock units Performance-Based Restricted Stock Units [Member] Performance-Based Restricted Stock Units Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Class of Stock [Axis] Class of Stock [Axis] Diluted net loss per common share (in dollars per share) Earnings Per Share, Diluted Counterparty Name [Domain] Counterparty Name [Domain] Revenue Recognition and Product Revenue, Net Revenue from Contract with Customer [Policy Text Block] Name Measure Name State State and Local Jurisdiction [Member] Entity Interactive Data Current Entity Interactive Data Current Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Fair value Cash, Cash Equivalents, and Short-Term Investments Intangible Assets Intangible Assets, Finite-Lived, Policy [Policy Text Block] Research and development - personnel and internal expense Research ​And ​Development​ Expense, Personnel And Internal Research ​And ​Development​ Expense, Personnel And Internal Deferred Tax Assets Components of Deferred Tax Assets [Abstract] Preferred stock, issued (in shares) Preferred Stock, Shares Issued Customer [Axis] Customer [Axis] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Valuation allowance on deferred tax assets (as a percent) Deferred Tax Assets, Percentage Of Valuation Allowance The percentage of valuation allowance on the deferred tax assets. Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Convertible Series A and B Preferred Stock Convertible Series A and B Preferred Stock [Member] Convertible Series A and B Preferred Stock [Member] Weighted average remaining contractual life (years) Share Based Compensation Arrangement by Share Based Payment Award, Options Outstanding Weighted Average Remaining Contractual Life [Abstract] Share Based Compensation Arrangement by Share Based Payment Award, Options Outstanding Weighted Average Remaining Contractual Life [Abstract] Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Research, Development and Commercialization Agreement Research Development And Commercialization Agreement [Member] Represents information pertaining to Research, Development and Commercialization Agreement with Hoffmann-La Roche ("Roche") which grants a sole and exclusive license to develop, use, sell, offer for sale and import any Licensed Product as defined by the agreement. Research and development credit Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount Total deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Other deferred tax liabilities Deferred Tax Liabilities, Other Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Income tax expense (benefit) Income Tax Expense (Benefit) Marketable securities Debt Securities, Available-for-Sale, Current Cash, Cash Equivalents and Marketable Securities Schedule of Investments [Line Items] Hercules warrant Adjustments to Additional Paid in Capital, Warrant Issued Weighted average remaining period (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Product revenue, net Revenue from Contract with Customer, Excluding Assessed Tax Acquisition of intangible asset Payments to Acquire Intangible Assets Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Milestone payment due Collaborative Arrangement, Contingent Consideration, Liability, Milestone Payment Collaborative Arrangement, Contingent Consideration, Liability, Milestone Payment Customer C Customer C [Member] Customer C Auditor Firm ID Auditor Firm ID Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Loss from operations Operating Income (Loss) Income Tax Jurisdiction [Axis] Income Tax Jurisdiction [Axis] Increase in domestic valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Research and development Research and Development Expense (Excluding Acquired in Process Cost) Number of reportable segments Number of Reportable Segments Total liabilities and stockholders’ equity Liabilities and Equity Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] All Adjustments to Compensation All Adjustments to Compensation [Member] Compensation and benefits Employee-related Liabilities, Current Marketable Securities Marketable Securities, Policy [Policy Text Block] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Other segment income (expense) Interest Income (Expense), Nonoperating Interest income Investment Income, Interest Summary of restricted stock unit activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Schedule of Maturities of Long-Term Debt Schedule of Maturities of Long-Term Debt [Table Text Block] Summary of Significant Accounting Policies Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Obtaining a right-of-use asset in exchange for a lease liability Right-of-use asset and lease liability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Underlying Security Market Price Change Underlying Security Market Price Change, Percent Individual: Individual [Axis] Accumulated other comprehensive income (loss) AOCI Attributable to Parent [Member] Options cancelled (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Customer A Customer A [Member] Customer A Inventory Total Inventory, Net Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] Product and Service [Axis] Product and Service [Axis] Entity Address, State or Province Entity Address, State or Province Statement Statement [Line Items] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Line of credit facility, number of withdrawals upon milestone achievements Line of Credit Facility, Number Of Withdrawals Upon Milestone Achievements Line of Credit Facility, Number Of Withdrawals Upon Milestone Achievements Chargebacks, Discounts for Prompt Pay and Other Allowances Chargebacks, Discounts for Prompt Pay and Other Allowances [Member] Chargebacks, Discounts for Prompt Pay and Other Allowances Expire In 2037 Expire In 2037 [Member] Expire in 2037. Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Major Types of Debt and Equity Securities [Domain] Financial Instruments [Domain] Equity instruments other than options, weighted average grant date fair value (in dollars per share) Outstanding, beginning balance (in dollars per share) Outstanding, ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Option to increase or decrease ownership percentage, term Class Of Warrant Or Right, Beneficial Ownership, Exercise Percentage Notice Period Class Of Warrant Or Right, Beneficial Ownership, Exercise Percentage Notice Period Restatement Determination Date Restatement Determination Date Public Stock Offering Public Stock Offering [Member] Public Stock Offering 2021 Sales Agreement Two Thousand and Twenty One Sales Agreement [Member] Two thousand and twenty one sales agreement. Adoption Date Trading Arrangement Adoption Date Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Cowen & Co. LLC Cowen Co. Llc [Member] Represent of Cowen & Co. LLC Member. Inducement Plan 2023 Inducement Plan 2023 [Member] Inducement Plan 2023 Contract with Customer, Asset, Allowance for Credit Loss [Roll Forward] Contract with Customer, Asset, Allowance for Credit Loss [Roll Forward] Outstanding, beginning balance (in dollars per share) Outstanding, ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Concentration Risk [Table] Concentration Risk [Table] Right-of-use asset Operating Lease, Right-of-Use Asset Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Outstanding, beginning balance (in shares) Outstanding, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Accounts receivable writeoff Accounts Receivable, Credit Loss Expense (Reversal) Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Tax Period [Axis] Tax Period [Axis] Purchasing period Sale Of Stock, Purchasing Period Sale Of Stock, Purchasing Period Long-term debt Long-Term Debt, Gross Exercise Price Award Exercise Price Variable Rate Component Two Variable Rate Component Two [Member] Variable Rate Component Two Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Audit Information [Abstract] Audit Information Arrangement Duration Trading Arrangement Duration Operating loss carryforwards Operating Loss Carryforwards Sale of warrants and common shares to related parties and exercise of common stock options, net of transaction costs Stock Issued During Period, Value, Stock Options Exercised Operating expenses: Costs and Expenses [Abstract] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Granted (in dollars per share) PSUs granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Federal Domestic Tax Jurisdiction [Member] Liquidity and Uncertainties Substantial Doubt about Going Concern [Text Block] Income Taxes Income Tax, Policy [Policy Text Block] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Accounts payable Increase (Decrease) in Accounts Payable, Trade All Individuals All Individuals [Member] PEO PEO [Member] Income Taxes Income Tax Disclosure [Abstract] Name Trading Arrangement, Individual Name Gross to net accrued liabilities Accrued Gross To Net Liabilities, Current Accrued Gross To Net Liabilities, Current Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Entity Public Float Entity Public Float Stock Plan 2015 Stock Plan 2015 [Member] Stock Plan 2015 Unrealized gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Schedules of Concentrations of Credit Risk and Significant Customers Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Stock options, restricted stock and performance stock units convertible, shares issuable (in shares) Common Stock, Capital Shares Granted And Issuable Common Stock, Capital Shares Granted And Issuable Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Other nondeductible expenses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount Common stock reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Related and Nonrelated Parties [Domain] Related and Nonrelated Parties [Domain] Total cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Total long term liabilities Liabilities, Noncurrent Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Cash, Cash Equivalents, Restricted Cash, and Marketable Securities Cash, Cash Equivalents, and Marketable Securities [Text Block] Local Phone Number Local Phone Number Valuation allowance Deferred Tax Assets, Valuation Allowance Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Stock-based compensation expense related to equity-classified awards APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Long term liabilities: Liabilities, Noncurrent [Abstract] Line of credit facility, increase (decrease) Line of Credit Facility, Increase (Decrease), Net Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Exercisable PEO Total Compensation Amount PEO Total Compensation Amount Preferred stock conversion ratio (in shares) Preferred Stock, Convertible, Conversion Ratio Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Axis] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Sales and maturities of marketable securities Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Common stock Common Stock [Member] Measure: Measure [Axis] Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Preferred stock, authorized (in shares) Preferred Stock, Shares Authorized Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Patents Patents [Policy Text Block] Disclosure of accounting policy for patents. Issuance of common and preferred shares in equity offerings, excluding to related parties, net of transaction costs (in shares) Stock Issued During Period, Shares, New Issues Line of Credit Line of Credit [Member] Entity Emerging Growth Company Entity Emerging Growth Company Income Statement [Abstract] Segment Reporting [Abstract] Entity Central Index Key Entity Central Index Key Provision for excess inventory Provision For Excess Inventory Provision For Excess Inventory Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Loan Facility, Tranche 1 Loan Facility, Tranche One [Member] Loan Facility, Tranche One Stockholders' Equity Equity [Text Block] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Equity Component [Domain] Equity Component [Domain] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Loan Facility Loan Facility [Member] Loan facility member. Financial Instrument [Axis] Financial Instrument [Axis] Segment Information Segment Reporting Disclosure [Text Block] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Entity Shell Company Entity Shell Company Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Title Trading Arrangement, Individual Title 2023 Sales Agreement Amendment Two Thousand And Twenty Three Sales Agreement Amendment [Member] Two Thousand And Twenty Three Sales Agreement [Member] Statement [Table] Statement [Table] Counterparty Name [Axis] Counterparty Name [Axis] Liability for uncertain tax positions Unrecognized Tax Benefits Other clinical study related costs Accrued Other Clinical Study Related Costs Current Accrued other clinical study related costs current. City Area Code City Area Code Public Offering, 2023 Public Offering, 2023 [Member] Public Offering, 2023 Current liabilities: Liabilities, Current [Abstract] Auditor Location Auditor Location Accrued expenses Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Schedule of Gross to Net Adjustments Reserve Schedule Of Gross To Net Adjustments Reserve [Table Text Block] Schedule Of Gross To Net Adjustments Reserve Total current assets Assets, Current U.S. Government and Government Sponsored Entities due within 1 year of date of purchase US Treasury And Government Due Within One Year [Member] US Treasury And Government Due Within One Year Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Revision of Prior Period [Domain] Revision of Prior Period [Domain] Proceeds from issuance of loan payable Proceeds from Bank Debt Preferred stock Preferred Stock [Member] Accrued liabilities Increase (Decrease) in Accrued Liabilities Tax Period [Domain] Tax Period [Domain] Exercisable at the end of the year (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number 2027 Long-Term Debt, Maturity, Year Three Payments and customer credits issued Gross To Net Adjustments Reserve Credits And Payments Made Gross To Net Adjustments Reserve Credits And Payments Made Hercules Warrants Hercules Warrants [Member] Hercules Warrants Schedule of Long-Term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Number of amendments Lessee, Operating Lease, Number Of Amendments Lessee, Operating Lease, Number Of Amendments Loan payable, net of discount Long-Term Debt, Excluding Current Maturities Weighted average grant date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Weighted-average grant date fair value of options (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Income Taxes Income Tax Disclosure [Text Block] Net loss per common share: Earnings Per Share [Abstract] Equity [Abstract] Raw materials Inventory, Raw Materials, Net of Reserves Accumulated deficit Retained Earnings (Accumulated Deficit) Class of Stock [Domain] Class of Stock [Domain] Inventory Increase (Decrease) in Inventories 2026 Long-Term Debt, Maturity, Year Two Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Equity Awards Adjustments Equity Awards Adjustments [Member] Weighted average, operating discount rate Operating Lease, Weighted Average Discount Rate, Percent Present value of lease liabilities Operating Lease, Liability Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Underlying Securities Award Underlying Securities Amount Performance-Based Restricted Stock Units (PSUs) Performance-based restricted stock units Performance Shares [Member] Income Taxes Operating Loss Carryforwards [Line Items] Credit Facility [Axis] Credit Facility [Axis] Amendment Flag Amendment Flag Entity Registrant Name Entity Registrant Name Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Depreciation and amortization expense Depreciation, Depletion and Amortization Fair Value as of Grant Date Award Grant Date Fair Value Customer Concentration Risk Customer Concentration Risk [Member] Revenue from Contract with Customer, Product and Service [Extensible Enumeration] Revenue from Contract with Customer, Product and Service [Extensible Enumeration] Selling, General and Administrative Expenses Selling, General and Administrative Expenses, Policy [Policy Text Block] Sale of stock, number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Long Term Debt Debt Disclosure [Text Block] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Debt instrument, face amount Debt Instrument, Face Amount Charitable contributions Deferred Tax Assets, Charitable Contribution Carryforwards Issuance of common shares in equity offerings, excluding to related parties, net of transaction costs Stock Issued During Period, Value, New Issues Entity Address, Postal Zip Code Entity Address, Postal Zip Code Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Variable Rate Component [Axis] Variable Rate Component [Axis] Variable Rate Component Principle of Consolidation Consolidation, Policy [Policy Text Block] Restatement Determination Date: Restatement Determination Date [Axis] Arrangements and Non-arrangement Transactions [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Title of 12(b) Security Title of 12(b) Security Concentration Risk Type [Axis] Concentration Risk Type [Axis] Common stock, par value $0.0001 per share authorized: 200,000,000 at December 31, 2024 and December 31, 2023; 22,004,679 and 19,875,427 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively Common Stock, Value, Issued Document Financial Statement Error Correction Document Financial Statement Error Correction [Flag] Share-Based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Schedule of Investments [Table] Schedule of Investments [Table] Remainder of future milestone payments Remaining Milestone Payments The amount of future milestone payments remaining to be paid under the agreement. Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Auditor Name Auditor Name Unrealized gains on investments Deferred Tax Liabilities, Unrealized Gains on Trading Securities Accrued Liabilities, Current [Abstract] Accrued Liabilities, Current [Abstract] Forfeited (in dollars per share) PSUs forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Concentration Risk [Line Items] Concentration Risk [Line Items] Preferred stock, par value $0.0001 per share authorized: 5,000,000 shares at December 31, 2024 and December 31, 2023; 2,369,797 and 2,369,797 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively Preferred Stock, Value, Issued State income taxes benefit before valuation allowance, net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Total Deferred Tax Liabilities Deferred Tax Liabilities, Gross Loan Facility, Tranche 2 Loan Facility, Tranche Two [Member] Loan Facility, Tranche Two Basic net loss per common share (in dollars per share) Earnings Per Share, Basic Operating lease payments Operating Lease, Payments Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Sale of stock, maximum required percentage of ownership after transaction Class Of Warrant Or Right, Beneficial Ownership, Maximum Threshold Class Of Warrant Or Right, Beneficial Ownership, Maximum Threshold Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Total current liabilities Liabilities, Current Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Balance, beginning Balance, ending Gross To Net Adjustments Reserve Gross To Net Adjustments Reserve Total assets Assets Cost of sales Cost of sales Cost of Goods and Services Sold Granted (in shares) PSUs granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Over-Allotment Option Over-Allotment Option [Member] U.S. Government and Government Sponsored Entities US Treasury and Government [Member] Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents [Abstract] Purchases of property and equipment, net of disposals Payments to Acquire Property, Plant, and Equipment U.S. Government and Government Sponsored Entities due within 1 to 2 years of date of purchase US Treasury And Government Due Within One To Two Years [Member] US Treasury And Government Due Within One To Two Years Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Schedule of Effective Income Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Termination Date Trading Arrangement Termination Date Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Exercise price of warrants (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Revenues Product revenue, net Revenues 2026 Lessee, Operating Lease, Liability, to be Paid, Year Two Unrealized loss on investment Deferred Tax Asset, Debt Securities, Trading, Unrealized Loss 2025 Long-Term Debt, Maturity, Year One Stock-based Compensation Share-Based Payment Arrangement [Text Block] Entity Address, City or Town Entity Address, City or Town Leases Lessee, Leases [Policy Text Block] Compensation expense related to stock options for services (in shares) Stock Issued During Period, Shares, Issued for Services Debt Instrument [Axis] Debt Instrument [Axis] Summary of stock option activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Total intrinsic value of options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Contract research organization costs Accrued Contract Research Costs Current Accrued Contract Research Costs, Current. Accrued interest, net of interest received on maturity of investments Increase (Decrease) In Accrued Interest, Net Of Interest Received The increase (decrease) during the reporting period in the aggregate amount of accrued interest expense incurred but not yet paid, net of interest received on maturity of investments. Stock-based compensation expense Share-Based Payment Arrangement, Expense Net loss Net Loss Net Income (Loss) Net Income (Loss) Attributable to Parent Trading Arrangement: Trading Arrangement [Axis] Other Commitments [Table] Other Commitments [Table] Options granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Forfeited (in shares) PSUs forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Current borrowing capacity Line of Credit Facility, Current Borrowing Capacity Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Maximum aggregate offering price Common Stock Aggregate Offering Price Represents the maximum aggregate offering price the entity may issue and sell shares of its common stock from time to time, at the entity's option, according to at-the-market issuance sales agreement with third party. Entity File Number Entity File Number 2022 Registered Direct Offering Two Thousand and Twenty Two Registered Direct Offering [Member] Two Thousand and Twenty Two Registered Direct Offering [Member] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Product Revenue, Net Revenue from Contract with Customer [Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Income Statement [Abstract] Income Statement [Abstract] Entity Address, Address Line One Entity Address, Address Line One Pre-Funded Warrants Pre-Funded Warrants [Member] Pre-Funded Warrants Entity Address, Address Line Two Entity Address, Address Line Two Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Other Other Accrued Liabilities, Current Name Forgone Recovery, Individual Name Exercisable at the end of the year Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Weighted average, operating lease term Operating Lease, Weighted Average Remaining Lease Term Line of credit facility, decrease In maximum borrowing capacity Line Of Credit Facility, Decrease In Maximum Borrowing Capacity Line Of Credit Facility, Decrease In Maximum Borrowing Capacity Document Period End Date Document Period End Date Sale of Stock [Axis] Sale of Stock [Axis] Finished goods Inventory, Finished Goods, Net of Reserves Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Total minimum payments Lessee, Operating Lease, Liability, to be Paid Deferred Tax Liabilities Components of Deferred Tax Liabilities [Abstract] Equity instruments other than options, outstanding (in shares) Outstanding, beginning balance (in shares) Outstanding, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Insider Trading Arrangements [Line Items] Inventory Disclosure [Abstract] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Warrants and rights outstanding Warrants and Rights Outstanding Adjustment to Compensation: Adjustment to Compensation [Axis] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Document Transition Report Document Transition Report Variable Rate Component [Domain] Variable Rate Component [Domain] Variable Rate Component [Domain] Customer [Domain] Customer [Domain] Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Current Reporting Status Entity Current Reporting Status Accumulated deficit Retained Earnings [Member] Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Related and Nonrelated Parties [Axis] Related and Nonrelated Parties [Axis] Basic weighted average number of common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Preferred shares number voting rights Preferred Stock, Number Of Voting Rights Number of voting rights of preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights. 2024 Sales Agreement 2024 Sales Agreement [Member] 2024 Sales Agreement Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Restricted stock units Restricted Stock Units (RSUs) [Member] Marketable securities, realized gain (loss) Debt Securities, Available-for-Sale, Realized Gain (Loss) Amortization of debt issuance costs and discount Amortization of Debt Issuance Costs and Discounts Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Professional fees Accrued Professional Fees, Current Executive Category: Executive Category [Axis] Name Awards Close in Time to MNPI Disclosures, Individual Name Bill Sibold [Member] Bill Sibold Revenue Benchmark Revenue Benchmark [Member] Options cancelled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Entity Filer Category Entity Filer Category Statement of Income Location, Balance [Domain] Statement of Income Location, Balance [Domain] Purchases of marketable securities Payments to Acquire Debt Securities, Available-for-Sale Company Selected Measure Name Company Selected Measure Name Product [Member]